Atossa gains on Rare Pediatric Disease status for Duchenne asset
Atossa Therapeutics (ATOS) is up ~11% in Thursday trading after reporting that the US FDA has granted Rare Pediatric Disease ...
Friday, June 19, 2026
Tag: Duchenne
-1024x683.jpg "Strait Outta Hormuz: Getting the Iran Oil Story Straight")
-1024x679.jpg "NATO Is Finding What Goes Around Comes Around")
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.